Showing results (71-80 of 319) with videos related to
Sort By:
Pageof 32
European Journal of Neurology|June 18, 2022
Anti-CD20 therapy for multiple sclerosis-associated uveitis: A case seriesFrauke Stascheit, Anne Rübsam, Carolin Otto, et al.Brain and Behavior|October 27, 2016
Fatigue in myasthenia gravis: risk factors and impact on quality of lifeSarah Hoffmann, Johanna Ramm, Ulrike Grittner, et al.Neurology|December 6, 2019
Myasthenic crisis demanding mechanical ventilation: A multicenter analysis of 250 casesBernhard Neumann, Klemens Angstwurm, Philipp Mergenthaler, et al.Journal of Neurology|September 27, 2022
Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravisFrauke Stascheit, Ulrike Grittner, Sarah Hoffmann, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 2, 2012
Decision-making in the diagnosis and treatment of stroke-associated pneumoniaHendrik Harms, Sarah Hoffmann, Uwe Malzahn, et al.Stroke|December 31, 2004
Folate deficiency increases postischemic brain injuryMatthias Endres, Michael Ahmadi, Inna Kruman, et al.BMJ Open|January 31, 2019
Bortezomib in antibody-mediated autoimmune diseases (TAVAB): study protocol for a unicentric, non-randomised, non-placebo controlled trialSiegfried Kohler, Stefanie Märschenz, Ulrike Grittner, et al.Journal of Neurology|September 19, 2018
Generalization after ocular onset in myasthenia gravis: a case series in GermanyFeng Li, Benjamin Hotter, Marc Swierzy, et al.Neuromuscular Disorders : NMD|May 19, 2025
278th ENMC International Workshop: European standards for harmonization of myasthenia gravis registries and emerging digital solutions. 20th-21st September 2024, Hoofddorp, The NetherlandsSabrina Sacconi, Fiammetta Vanoli, Frauke Stascheit, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 5, 2022
Eculizumab versus rituximab in generalised myasthenia gravisChristopher Nelke, Christina B Schroeter, Frauke Stascheit, et al.Pageof 32